Compositions and methods for chronic use of a weight-gaining compound
AssigneeAratana Therapeutics, Inc.
InventorsLinda Rhodes, Marie-Paul Lachaud, Bill Zollers, Ernst Heinen
Life of this patent
Estimating the term…
Loading patent…
AssigneeAratana Therapeutics, Inc.
InventorsLinda Rhodes, Marie-Paul Lachaud, Bill Zollers, Ernst Heinen
Estimating the term…
Provided herein is a method of binding growth hormone secretagogue receptors in one or more companion animals or livestock to stimulate hunger independent of release of growth hormone. The method can provide administering a therapeutically effective amount of a capromorelin-containing composition to a companion animal or livestock in need thereof for a period of at least 30 days. Optionally, one or more flavoring agents or flavor-masking agents can be added to the capromorelin-containing composition to enhance or mask the flavoring of the composition for the companion animal or livestock.
A method of binding growth hormone secretagogue receptors (GHS-Rs) with capromorelin in the hypothalamus of a companion animal or livestock,
The method of claim 8, wherein the capromorelin-containing composition comprises about 2 milligrams of capromorelin per kilogram of bodyweight of the companion animal or livestock per day.
A method of binding growth hormone secretagogue receptors (GHS-Rs) with capromorelin in the hypothalamus of a companion animal or livestock to increase lean muscle mass and to increase weight gain,
A method of binding growth hormone secretagogue receptors (GHS-Rs) with capromorelin in the hypothalamus of companion animal or livestock with chronic kidney disease (CKD) to treat weight loss,
Dependencies are inferred from the claim text.